The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Adcortyl Intra-articular/Intradermal Injection 10 mg/ml, Suspension for Injection, 5ml

10 milligram(s)/millilitre Suspension for injection

Bristol-Myers Squibb Pharmaceuticals ucPA0002/018/003

Main Information

Trade NameAdcortyl Intra-articular/Intradermal Injection 10 mg/ml, Suspension for Injection, 5ml
Active SubstancesTriamcinolone acetonide
Strength10 milligram(s)/millilitre
Dosage FormSuspension for injection
Licence HolderBristol-Myers Squibb Pharmaceuticals uc
Licence NumberPA0002/018/003

Group Information

ATC CodeH02AB Glucocorticoids
H02AB08 triamcinolone


Licence Issued01/04/1978
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back